
Avinger AVGR
Quarterly report 2024-Q3
added 11-07-2024
Avinger Interest Expense 2011-2026 | AVGR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.72 M | 1.66 M | 1.65 M | 1.69 M | 1.48 M | 5.69 M | 6.3 M | 5.52 M | 5.17 M | 6.02 M | 2.93 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.3 M | 1.48 M | 3.62 M |
Quarterly Interest Expense Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48 K | 234 K | 416 K | - | 455 K | 445 K | 392 K | - | 407 K | 440 K | 439 K | - | 419 K | 399 K | 396 K | - | 433 K | 414 K | 398 K | - | 377 K | 364 K | 350 K | - | 324 K | 362 K | 4.67 M | - | 1.6 M | 1.57 M | 1.55 M | - | 1.55 M | 1.24 M | 1.17 M | - | 1.33 M | 1.34 M | 1.32 M | - | 1.71 M | 1.62 M | 1.57 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.67 M | 48 K | 902 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.94 | -1.08 % | $ 1.61 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.07 | -3.3 % | $ 257 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 23.78 | 0.72 % | $ 201 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 36.67 | -0.19 % | $ 5.46 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 90.0 | 1.58 % | $ 12.2 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.58 | -0.11 % | $ 122 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.83 | -3.68 % | $ 1.11 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.33 | 0.21 % | $ 719 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.4 | -1.73 % | $ 127 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 85.11 | -0.61 % | $ 2.96 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 166.87 | -2.91 % | $ 12.5 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
AxoGen
AXGN
|
167 K | $ 30.99 | -5.06 % | $ 1.43 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.76 | -1.13 % | $ 370 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.63 | -4.41 % | $ 67.3 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.42 | 0.15 % | $ 111 B | ||
|
Myomo
MYO
|
-668 K | $ 0.68 | -2.9 % | $ 28.5 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.05 | -1.94 % | $ 857 M | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.67 | -0.31 % | $ 346 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 61.86 | -1.12 % | $ 91.6 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.03 | 0.55 % | $ 1.66 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 202.46 | -0.51 % | $ 14.2 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.54 | 1.35 % | $ 1.07 B |